Showing results (71-80 of 172) with videos related to
Sort By:
Pageof 18
Frontiers in Cellular and Infection Microbiology|June 14, 2019
Bioactivity of Farnesyltransferase Inhibitors Against <i>Entamoeba histolytica</i> and <i>Schistosoma mansoni</i>Alexandra Probst, Thi N Nguyen, Nelly El-Sakkary, et al.Bioorganic & Medicinal Chemistry Letters|February 3, 2023
Activity of N-phenylbenzamide analogs against the neglected disease pathogen, Schistosoma mansoniMasebe Kanyanta, Chilufya Lengwe, Dickson Mambwe, et al.BMC Immunology|November 17, 2010
Rapid induction of IgE responses to a worm cysteine protease during murine pre-patent schistosome infectionLucia A de Oliveira Fraga, Erika W Lamb, Elizabeth C Moreno, et al.The Journal of Biological Chemistry|August 15, 2008
A parasite cysteine protease is key to host protein degradation and iron acquisitionTheresa C O'Brien, Zachary B Mackey, Richard D Fetter, et al.Pharmaceutical Research|December 19, 2018
High Throughput and Computational Repurposing for Neglected DiseasesHelen W Hernandez, Melinda Soeung, Kimberley M Zorn, et al.Journal of Medicinal Chemistry|January 5, 2008
Development of potent purine-derived nitrile inhibitors of the trypanosomal protease TbcatBJeremy P Mallari, Anang A Shelat, Terri Obrien, et al.Parasites & Vectors|October 24, 2019
Multi-center screening of the Pathogen Box collection for schistosomiasis drug discoveryMartina Maccesi, Pedro H N Aguiar, Valérian Pasche, et al.Journal of Medicinal Chemistry|April 18, 2008
Aza-peptidyl Michael acceptors. A new class of potent and selective inhibitors of asparaginyl endopeptidases (legumains) from evolutionarily diverse pathogensMarion G Götz, Karen Ellis James, Elizabeth Hansell, et al.International Journal for Parasitology. Drugs and Drug Resistance|December 4, 2018
TPT sulfonate, a single, oral dose schistosomicidal prodrug: In vivo efficacy, disposition and metabolic profilingAlan R Wolfe, R Jeffrey Neitz, Mark Burlingame, et al.Biological Chemistry|August 10, 2006
Production and processing of a recombinant Fasciola hepatica cathepsin B-like enzyme (FhcatB1) reveals potential processing mechanisms in the parasiteSimone A Beckham, Ruby H-P Law, Peter M Smooker, et al.Pageof 18